Lipidomic strategies to study structural and functional defects of ABC-transporters in cellular lipid trafficking

FEBS Letters

Volumn 580, Issue 23, 2006, Pages 5597-5610

  Schmitz, Gerd ^a   Liebisch, Gerhard ^a   Langmann, Thomas ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

ABC transporters; Lipid trafficking disorders; Lipidomics

Indexed keywords

ABC TRANSPORTER; FATTY ACID; MEMBRANE LIPID; MESSENGER RNA; PHOSPHOLIPID; STEROL;

ADRENOLEUKODYSTROPHY; CELL TRANSPORT; DNA MICROARRAY; FLOW CYTOMETRY; FLUORESCENCE; GAS CHROMATOGRAPHY; GENE EXPRESSION; GENE MUTATION; GENETIC DISORDER; HIGH THROUGHPUT SCREENING; HOMEOSTASIS; HUMAN; INTRAHEPATIC CHOLESTASIS; LIPID COMPOSITION; LIPID METABOLISM; LIPID TRANSPORT; MASS SPECTROMETRY; MONITORING; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHORT SURVEY; SJOEGREN SYNDROME; STRUCTURE ANALYSIS; TANGIER DISEASE; TECHNOLOGY;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; DISEASE; HUMANS; LIPID METABOLISM; PHENOTYPE;

ANIMALIA;

EID: 33749044786     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.08.014     Document Type: Short Survey

References (140)

1. Higgins C.F. ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol. 8 (1992) 67-113
2. Ueda K., Matsuo M., Tanabe K., Morita K., Kioka N., and Amachi T. Comparative aspects of the function and mechanism of SUR1 and MDR1 proteins. Biochim. Biophys. Acta 1461 (1999) 305-313
3. Szakacs G., Langmann T., Ozvegy C., Orso E., Schmitz G., Varadi A., and Sarkadi B. Characterization of the ATPase cycle of human ABCA1: implications for its function as a regulator rather than an active transporter. Biochem. Biophys. Res. Commun. 288 (2001) 1258-1264
4. Dean M., and Allikmets R. Complete characterization of the human ABC gene family. J. Bioenerg. Biomembr. 33 (2001) 475-479
5. Ho G.T., Nimmo E.R., Tenesa A., Fennell J., Drummond H., Mowat C., Arnott I.D., and Satsangi J. Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. Gastroenterology 128 (2005) 288-296
6. Mace S., Cousin E., Ricard S., Genin E., Spanakis E., Lafargue-Soubigou C., Genin B., Fournel R., Roche S., Haussy G., Massey F., Soubigou S., Brefort G., Benoit P., Brice A., Campion D., Hollis M., Pradier L., Benavides J., and Deleuze J.F. ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease. Neurobiol. Dis. 18 (2005) 119-125
7. Bodzioch M., Orso E., Klucken J., Langmann T., Bottcher A., Diederich W., Drobnik W., Barlage S., Buchler C., Porsch-Ozcurumez M., Kaminski W.E., Hahmann H.W., Oette K., Rothe G., Aslanidis C., Lackner K.J., and Schmitz G. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22 (1999) 347-351
8. Brooks-Wilson A., Marcil M., Clee S.M., Zhang L.H., Roomp K., van Dam M., Yu L., Brewer C., Collins J.A., Molhuizen H.O., Loubser O., Ouelette B.F., Fichter K., Ashbourne-Excoffon K.J., Sensen C.W., Scherer S., Mott S., Denis M., Martindale D., Frohlich J., Morgan K., Koop B., Pimstone S., Kastelein J.J., and Hayden M.R. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22 (1999) 336-345
9. Rust S., Rosier M., Funke H., Real J., Amoura Z., Piette J.C., Deleuze J.F., Brewer H.B., Duverger N., Denefle P., and Assmann G. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22 (1999) 352-355
10. Asztalos B.F., Brousseau M.E., McNamara J.R., Horvath K.V., Roheim P.S., and Schaefer E.J. Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease. Atherosclerosis 156 (2001) 217-225
11. Tall A.R., and Wang N. Tangier disease as a test of the reverse cholesterol transport hypothesis. J. Clin. Invest 106 (2000) 1205-1207
12. Clee S.M., Kastelein J.J., van Dam M., Marcil M., Roomp K., Zwarts K.Y., Collins J.A., Roelants R., Tamasawa N., Stulc T., Suda T., Ceska R., Boucher B., Rondeau C., DeSouich C., Brooks-Wilson A., Molhuizen H.O., Frohlich J., Genest Jr. J., and Hayden M.R. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J. Clin. Invest. 106 (2000) 1263-1270
13. Clee S.M., Zwinderman A.H., Engert J.C., Zwarts K.Y., Molhuizen H.O., Roomp K., Jukema J.W., van Wijland M., van Dam M., Hudson T.J., Brooks-Wilson A., Genest Jr. J., Kastelein J.J., and Hayden M.R. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 103 (2001) 1198-1205
14. Schmitz G., and Kaminski W.E. ABC transporters and cholesterol metabolism. Front Biosci. 6 (2001) D505-D514
15. Schmitz G., and Langmann T. Structure, function and regulation of the ABC1 gene product. Curr. Opin. Lipidol. 12 (2001) 129-140
16. Probst M.C., Thumann H., Aslanidis C., Langmann T., Buechler C., Patsch W., Baralle F.E., Dallinga-Thie G.M., Geisel J., Keller C., Menys V.C., and Schmitz G. Screening for functional sequence variations and mutations in ABCA1. Atherosclerosis 175 (2004) 269-279
17. Langmann T., Mauerer R., Zahn A., Moehle C., Probst M., Stremmel W., and Schmitz G. Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues. Clin. Chem. 49 (2003) 230-238
18. Lin C.Y., Strom A., Vega V.B., Kong S.L., Yeo A.L., Thomsen J.S., Chan W.C., Doray B., Bangarusamy D.K., Ramasamy A., Vergara L.A., Tang S., Chong A., Bajic V.B., Miller L.D., Gustafsson J.A., and Liu E.T. Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells. Genome Biol. 5 (2004) R66
19. Yamano G., Funahashi H., Kawanami O., Zhao L.X., Ban N., Uchida Y., Morohoshi T., Ogawa J., Shioda S., and Inagaki N. ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells(1). FEBS Lett. 508 (2001) 221-225
20. Cheong N., Madesh M., Gonzales L.W., Zhao M., Yu K., Ballard P.L., and Shuman H. Functional and trafficking defects in ATP binding cassette A3 mutants associated with respiratory distress syndrome. J. Biol. Chem. 281 (2006) 9791-9800
21. Bullard J.E., Wert S.E., Whitsett J.A., Dean M., and Nogee L.M. ABCA3 mutations associated with pediatric interstitial lung disease. Am. J. Respir. Crit. Care Med. 172 (2005) 1026-1031
22. Shulenin S., Nogee L.M., Annilo T., Wert S.E., Whitsett J.A., and Dean M. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N. Engl. J. Med. 350 (2004) 1296-1303
23. Brasch F., Schimanski S., Muehlfeld C., Barlage S., Langmann T., Aslanidis C., Boettcher A., Dada A., Schroten H., Mildenberger E., Prueter E., Ballmann M., Ochs M., Johnen G., Griese M., and Schmitz G. Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency. Am. J. Respir. Crit. Care Med. (2006)
24. Kielar D., Kaminski W.E., Liebisch G., Piehler A., Wenzel J.J., Mohle C., Heimerl S., Langmann T., Friedrich S.O., Bottcher A., Barlage S., Drobnik W., and Schmitz G. Adenosine triphosphate binding cassette (ABC) transporters are expressed and regulated during terminal keratinocyte differentiation: a potential role for ABCA7 in epidermal lipid reorganization. J. Invest. Dermatol. 121 (2003) 465-474
25. Wang N., Lan D., Gerbod-Giannone M., Linsel-Nitschke P., Jehle A.W., Chen W., Martinez L.O., and Tall A.R. ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein A-I and mediates cellular phospholipid but not cholesterol efflux. J. Biol. Chem. 278 (2003) 42906-42912
26. Abe-Dohmae S., Ikeda Y., Matsuo M., Hayashi M., Okuhira K., Ueda K., and Yokoyama S. Human ABCA7 supports apolipoprotein-mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein. J. Biol. Chem. 279 (2004) 604-611
27. Kim W.S., Fitzgerald M.L., Kang K., Okuhira K., Bell S.A., Manning J.J., Koehn S.L., Lu N., Moore K.J., and Freeman M.W. Abca7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levels. J. Biol. Chem. 280 (2005) 3989-3995
28. Kaminski W.E., Piehler A., and Schmitz G. Genomic organization of the human cholesterol-responsive ABC transporter ABCA7: tandem linkage with the minor histocompatibility antigen HA-1 gene. Biochem. Biophys. Res. Commun. 278 (2000) 782-789
29. Ikeda Y., be-Dohmae S., Munehira Y., Aoki R., Kawamoto S., Furuya A., Shitara K., Amachi T., Kioka N., Matsuo M., Yokoyama S., and Ueda K. Posttranscriptional regulation of human ABCA7 and its function for the apoA-I-dependent lipid release. Biochem. Biophys. Res. Commun. 311 (2003) 313-318
30. Abe-Dohmae S., Ueda K., and Yokoyama S. ABCA7, a molecule with unknown function. FEBS Lett. 580 (2006) 1178-1182
31. den Haan J.M., Meadows L.M., Wang W., Pool J., Blokland E., Bishop T.L., Reinhardus C., Shabanowitz J., Offringa R., Hunt D.F., Engelhard V.H., and Goulmy E. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science 279 (1998) 1054-1057
32. Iwamoto N., Abe-Dohmae S., Sato R., and Yokoyama S. ATP-binding cassette transporter A7 expression is regulated by cellular cholesterol through the sterol responsive/regulatory element 2 pathway and associated with phagocytic activity. J. Lipid Res. (2006)
33. Tanaka A.R., Ikeda Y., Abe-Dohmae S., Arakawa R., Sadanami K., Kidera A., Nakagawa S., Nagase T., Aoki R., Kioka N., Amachi T., Yokoyama S., and Ueda K. Human ABCA1 contains a large amino-terminal extracellular domain homologous to an epitope of Sjogren's syndrome. Biochem. Biophys. Res. Commun. 283 (2001) 1019-1025
34. Harangi M., Kaminski W.E., Fleck M., Orso E., Zeher M., Kiss E., Szekanecz Z., Zilahi E., Marienhagen J., Aslanidis C., Paragh G., Bolstad A.I., Jonsson R., and Schmitz G. Homozygosity for the 168His variant of the minor histocompatibility antigen HA-1 is associated with reduced risk of primary Sjogren's syndrome. Eur. J. Immunol. 35 (2005) 305-317
35. Toda Y., Aoki R., Ikeda Y., Azuma Y., Kioka N., Matsuo M., Sakamoto M., Mori S., Fukumoto M., and Ueda K. Detection of ABCA7-positive cells in salivary glands from patients with Sjogren's syndrome. Pathol. Int. 55 (2005) 639-643
36. Annilo T., Shulenin S., Chen Z.Q., Arnould I., Prades C., Lemoine C., Maintoux-Larois C., Devaud C., Dean M., Denefle P., and Rosier M. Identification and characterization of a novel ABCA subfamily member, ABCA12, located in the lamellar ichthyosis region on 2q34. Cytogenet. Genome Res. 98 (2002) 169-176
37. Parmentier L., Clepet C., Boughdene-Stambouli O., Lakhdar H., Blanchet-Bardon C., Dubertret L., Wunderle E., Pulcini F., Fizames C., and Weissenbach J. Lamellar ichthyosis: further narrowing, physical and expression mapping of the chromosome 2 candidate locus. Eur. J. Hum. Genet. 7 (1999) 77-87
38. Lefevre C., Audebert S., Jobard F., Bouadjar B., Lakhdar H., Boughdene-Stambouli O., Blanchet-Bardon C., Heilig R., Foglio M., Weissenbach J., Lathrop M., Prud'homme J.F., and Fischer J. Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2. Hum. Mol. Genet. 12 (2003) 2369-2378
39. Akiyama M., Sugiyama-Nakagiri Y., Sakai K., McMillan J.R., Goto M., Arita K., Tsuji-Abe Y., Tabata N., Matsuoka K., Sasaki R., Sawamura D., and Shimizu H. Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer. J. Clin. Invest. 115 (2005) 1777-1784
40. Kelsell D.P., Norgett E.E., Unsworth H., Teh M.T., Cullup T., Mein C.A., Dopping-Hepenstal P.J., Dale B.A., Tadini G., Fleckman P., Stephens K.G., Sybert V.P., Mallory S.B., North B.V., Witt D.R., Sprecher E., Taylor A.E., Ilchyshyn A., Kennedy C.T., Goodyear H., Moss C., Paige D., Harper J.I., Young B.D., Leigh I.M., Eady R.A., and O'Toole E.A. Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis. Am. J. Hum. Genet. 76 (2005) 794-803
41. Elias P.M. Stratum corneum defensive functions: an integrated view. J. Invest. Dermatol. 125 (2005) 183-200
42. Harris M.J., Le Couteur D.G., and Arias I.M. Progressive familial intrahepatic cholestasis: genetic disorders of biliary transporters. J. Gastroenterol. Hepatol. 20 (2005) 807-817
43. Strautnieks S.S., Bull L.N., Knisely A.S., Kocoshis S.A., Dahl N., Arnell H., Sokal E., Dahan K., Childs S., Ling V., Tanner M.S., Kagalwalla A.F., Nemeth A., Pawlowska J., Baker A., Mieli-Vergani G., Freimer N.B., Gardiner R.M., and Thompson R.J. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat. Genet. 20 (1998) 233-238
44. Jacquemin E., de Vree J.M., Cresteil D., Sokal E.M., Sturm E., Dumont M., Scheffer G.L., Paul M., Burdelski M., Bosma P.J., Bernard O., Hadchouel M., and Elferink R.P. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 120 (2001) 1448-1458
45. Smit J.J., Schinkel A.H., Oude Elferink R.P., Groen A.K., Wagenaar E., van Deemter L., Mol C.A., Ottenhoff R., van der Lugt N.M., and van Roon M.A. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75 (1993) 451-462
46. Takano H., Koike R., Onodera O., and Tsuji S. Mutational analysis of X-linked adrenoleukodystrophy gene. Cell Biochem. Biophys. 32 Spring (2000) 177-185
47. Clayton P.T. Clinical consequences of defects in peroxisomal beta-oxidation. Biochem. Soc. Trans. 29 (2001) 298-305
48. Wanders R.J., van Grunsven E.G., and Jansen G.A. Lipid metabolism in peroxisomes: enzymology, functions and dysfunctions of the fatty acid alpha- and beta-oxidation systems in humans. Biochem. Soc. Trans. 28 (2000) 141-149
49. Netik A., Forss-Petter S., Holzinger A., Molzer B., Unterrainer G., and Berger J. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy. Hum. Mol. Genet. 8 (1999) 907-913
50. Turley S.D., and Dietschy J.M. Sterol absorption by the small intestine. Curr. Opin. Lipidol. 14 (2003) 233-240
51. Lee M.H., Lu K., Hazard S., Yu H., Shulenin S., Hidaka H., Kojima H., Allikmets R., Sakuma N., Pegoraro R., Srivastava A.K., Salen G., Dean M., and Patel S.B. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat. Genet. 27 (2001) 79-83
52. Berge K.E., Tian H., Graf G.A., Yu L., Grishin N.V., Schultz J., Kwiterovich P., Shan B., Barnes R., and Hobbs H.H. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290 (2000) 1771-1775
53. Remaley A.T., Bark S., Walts A.D., Freeman L., Shulenin S., Annilo T., Elgin E., Rhodes H.E., Joyce C., Dean M., Santamarina-Fojo S., and Brewer Jr. H.B. Comparative genome analysis of potential regulatory elements in the ABCG5-ABCG8 gene cluster. Biochem. Biophys. Res. Commun. 295 (2002) 276-282
54. Lammert F., and Wang D.Q. New insights into the genetic regulation of intestinal cholesterol absorption. Gastroenterology 129 (2005) 718-734
55. Yu L., Hammer R.E., Li-Hawkins J., Von Bergmann K., Lutjohann D., Cohen J.C., and Hobbs H.H. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc. Natl. Acad. Sci. USA 99 (2002) 16237-16242
56. Yu L., Li-Hawkins J., Hammer R.E., Berge K.E., Horton J.D., Cohen J.C., and Hobbs H.H. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J. Clin. Invest. 110 (2002) 671-680
57. Yu L., York J., Von Bergmann K., Lutjohann D., Cohen J.C., and Hobbs H.H. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J. Biol. Chem. 278 (2003) 15565-15570
58. Langheim S., Yu L., von B.K., Lutjohann D., Xu F., Hobbs H.H., and Cohen J.C. ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile. J. Lipid Res. 46 (2005) 1732-1738
59. Orso E., Broccardo C., Kaminski W.E., Bottcher A., Liebisch G., Drobnik W., Gotz A., Chambenoit O., Diederich W., Langmann T., Spruss T., Luciani M.F., Rothe G., Lackner K.J., Chimini G., and Schmitz G. Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice. Nat. Genet. 24 (2000) 192-196
60. Singaraja R.R., Fievet C., Castro G., James E.R., Hennuyer N., Clee S.M., Bissada N., Choy J.C., Fruchart J.C., McManus B.M., Staels B., and Hayden M.R. Increased ABCA1 activity protects against atherosclerosis. J. Clin. Invest. 110 (2002) 35-42
61. Timmins J.M., Lee J.Y., Boudyguina E., Kluckman K.D., Brunham L.R., Mulya A., Gebre A.K., Coutinho J.M., Colvin P.L., Smith T.L., Hayden M.R., Maeda N., and Parks J.S. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J. Clin. Invest. 115 (2005) 1333-1342
62. Brunham L.R., Kruit J.K., Iqbal J., Fievet C., Timmins J.M., Pape T.D., Coburn B.A., Bissada N., Staels B., Groen A.K., Hussain M.M., Parks J.S., Kuipers F., and Hayden M.R. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J. Clin. Invest. 116 (2006) 1052-1062
63. Aiello R.J., Brees D., and Francone O.L. ABCA1-deficient mice: insights into the role of monocyte lipid efflux in HDL formation and inflammation. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 972-980
64. Langmann T., Porsch-Ozcurumez M., Heimerl S., Probst M., Moehle C., Taher M., Borsukova H., Kielar D., Kaminski W.E., Dittrich-Wengenroth E., and Schmitz G. Identification of sterol-independent regulatory elements in the human ATP-binding cassette transporter A1 promoter: role of Sp1/3, E-box binding factors, and an oncostatin M-responsive element. J. Biol. Chem. 277 (2002) 14443-14450
65. Remaley A.T., Rust S., Rosier M., Knapper C., Naudin L., Broccardo C., Peterson K.M., Koch C., Arnould I., Prades C., Duverger N., Funke H., Assman G., Dinger M., Dean M., Chimini G., Santamarina F.S., Fredrickson D.S., Denefle P., and Brewer-HB J. Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. Proc. Natl. Acad. Sci. USA 96 (1999) 12685-12690
66. Cavelier L.B., Qiu Y., Bielicki J.K., Afzal V., Cheng J.F., and Rubin E.M. Regulation and activity of the human ABCA1 gene in transgenic mice. J. Biol. Chem. 276 (2001) 18046-18051
67. Santamarina-Fojo S., Remaley A.T., Neufeld E.B., and Brewer Jr. H.B. Regulation and intracellular trafficking of the ABCA1 transporter. J. Lipid Res. 42 (2001) 1339-1345
68. Haidar B., Denis M., Marcil M., Krimbou L., and Genest Jr. J. Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter. J. Biol. Chem. 279 (2004) 9963-9969
69. Oram J.F., Lawn R.M., Garvin M.R., and Wade D.P. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem. 275 (2000) 34508-34511
70. Tang C., Vaughan A.M., and Oram J.F. Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol. J. Biol. Chem. 279 (2004) 7622-7628
71. Martinez L.O., Agerholm-Larsen B., Wang N., Chen W., and Tall A.R. Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. J. Biol. Chem. 278 (2003) 37368-37374
72. Wang Y., and Oram J.F. Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1. J. Biol. Chem. 277 (2002) 5692-5697
73. Wang Y., Kurdi-Haidar B., and Oram J.F. LXR-mediated activation of macrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilize ABCA1. J. Lipid Res. 45 (2004) 972-980
74. Diederich W., Orso E., Drobnik W., and Schmitz G. Apolipoprotein AI and HDL(3) inhibit spreading of primary human monocytes through a mechanism that involves cholesterol depletion and regulation of CDC42. Atherosclerosis 159 (2001) 313-324
75. Tsukamoto K., Hirano K., Tsujii K., Ikegami C., Zhongyan Z., Nishida Y., Ohama T., Matsuura F., Yamashita S., and Matsuzawa Y. ATP-binding cassette transporter-1 induces rearrangement of actin cytoskeletons possibly through Cdc42/N-WASP. Biochem. Biophys. Res. Commun. 287 (2001) 757-765
76. Buechler C., Boettcher A., Bared S.M., Probst M.C., and Schmitz G. The carboxyterminus of the ATP-binding cassette transporter A1 interacts with a beta2-syntrophin/utrophin complex. Biochem. Biophys. Res. Commun. 293 (2002) 759-765
77. Munehira Y., Ohnishi T., Kawamoto S., Furuya A., Shitara K., Imamura M., Yokota T., Takeda S., Amachi T., Matsuo M., Kioka N., and Ueda K. Alpha1-syntrophin modulates turnover of ABCA1. J. Biol. Chem. 279 (2004) 15091-15095
78. Engel T., Lueken A., Bode G., Hobohm U., Lorkowski S., Schlueter B., Rust S., Cullen P., Pech M., Assmann G., and Seedorf U. ADP-ribosylation factor (ARF)-like 7 (ARL7) is induced by cholesterol loading and participates in apolipoprotein AI-dependent cholesterol export. FEBS Lett. 566 (2004) 241-246
79. Bared S.M., Buechler C., Boettcher A., Dayoub R., Sigruener A., Grandl M., Rudolph C., Dada A., and Schmitz G. Association of ABCA1 with syntaxin 13 and flotillin-1 and enhanced phagocytosis in tangier cells. Mol. Biol. Cell 15 (2004) 5399-5407
80. Kennedy M.A., Venkateswaran A., Tarr P.T., Xenarios I., Kudoh J., Shimizu N., and Edwards P.A. Characterization of the human abcg1 gene. liver x receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein. J. Biol. Chem. 276 (2001) 39438-39447
81. Langmann T., Porsch-Ozcurumez M., Unkelbach U., Klucken J., and Schmitz G. Genomic organization and characterization of the promoter of the human ATP-binding cassette transporter-G1 (ABCG1) gene. Biochim. Biophys. Acta 1494 (2000) 175-180
82. Lorkowski S., Rust S., Engel T., Jung E., Tegelkamp K., Galinski E.A., Assmann G., and Cullen P. Genomic sequence and structure of the human ABCG1 (ABC8) gene. Biochem. Biophys. Res. Commun. 280 (2001) 121-131
83. Nakamura K., Kennedy M.A., Baldan A., Bojanic D.D., Lyons K., and Edwards P.A. Expression and regulation of multiple murine ATP-binding cassette transporter G1 mRNAs/isoforms that stimulate cellular cholesterol efflux to high density lipoprotein. J. Biol. Chem. 279 (2004) 45980-45989
84. Simpson F., Peden A.A., Christopoulou L., and Robinson M.S. Characterization of the adaptor-related protein complex, AP-3. J.Cell Biol. 137 (1997) 835-845
85. Schmitz G., Langmann T., and Heimerl S. Role of ABCG1 and other ABCG family members in lipid metabolism. J. Lipid Res. 42 (2001) 1513-1520
86. Klucken J., Buchler C., Orso E., Kaminski W.E., Porsch-Ozcurumez M., Liebisch G., Kapinsky M., Diederich W., Drobnik W., Dean M., Allikmets R., and Schmitz G. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc. Natl. Acad. Sci. USA 97 (2000) 817-822
87. Wang N., Lan D., Chen W., Matsuura F., and Tall A.R. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl. Acad. Sci. USA 101 (2004) 9774-9779
88. Cserepes J., Szentpetery Z., Seres L., Ozvegy-Laczka C., Langmann T., Schmitz G., Glavinas H., Klein I., Homolya L., Varadi A., Sarkadi B., and Elkind N.B. Functional expression and characterization of the human ABCG1 and ABCG4 proteins: indications for heterodimerization. Biochem. Biophys. Res. Commun. 320 (2004) 860-867
89. Kennedy M.A., Barrera G.C., Nakamura K., Baladan A., Tarr P., Fishbein M.C., Frank J., Francone O., and Edwards P.A. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 1 (2005) 121-131
90. Brewer Jr. H.B., and Santamarina-Fojo S. New insights into the role of the adenosine triphosphate-binding cassette transporters in high-density lipoprotein metabolism and reverse cholesterol transport. Am. J. Cardiol. 91 (2003) 3E-11E
91. Baldan A., Tarr P., Lee R., and Edwards P.A. ATP-binding cassette transporter G1 and lipid homeostasis. Curr. Opin. Lipidol. 17 (2006) 227-232
92. Schmitz G., Robenek H., Lohmann U., and Assmann G. Interaction of high density lipoproteins with cholesteryl ester-laden macrophages: biochemical and morphological characterization of cell surface receptor binding, endocytosis and resecretion of high density lipoproteins by macrophages. EMBO J. 4 (1985) 613-622
93. Neufeld E.B., Remaley A.T., Demosky S.J., Stonik J.A., Cooney A.M., Comly M., Dwyer N.K., Zhang M., Blanchette-Mackie J., Santamarina-Fojo S., and Brewer Jr. H.B. Cellular localization and trafficking of the human ABCA1 transporter. J. Biol. Chem. 276 (2001) 27584-27590
94. Neufeld E.B., Stonik J.A., Demosky Jr. S.J., Knapper C.L., Combs C.A., Cooney A., Comly M., Dwyer N., Blanchette-Mackie J., Remaley A.T., Santamarina-Fojo S., and Brewer Jr. H.B. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease. J. Biol. Chem. 279 (2004) 15571-15578
95. Drobnik W., Borsukova H., Bottcher A., Pfeiffer A., Liebisch G., Schutz G.J., Schindler H., and Schmitz G. Apo AI/ABCA1-dependent and HDL3-mediated lipid efflux from compositionally distinct cholesterol-based microdomains. Traffic 3 (2002) 268-278
96. Hinrichs J.W., Klappe K., van Riezen M., and Kok J.W. Drug resistance-associated changes in sphingolipids and ABC transporters occur in different regions of membrane domains. J. Lipid Res. 46 (2005) 2367-2376
97. Gaus K., Kritharides L., Schmitz G., Boettcher A., Drobnik W., Langmann T., Quinn C.M., Death A., Dean R.T., and Jessup W. Apolipoprotein A-1 interaction with plasma membrane lipid rafts controls cholesterol export from macrophages. FASEB J. 18 (2004) 574-576
98. Ito J., Nagayasu Y., and Yokoyama S. Cholesterol-sphingomyelin interaction in membrane and apolipoprotein-mediated cellular cholesterol efflux. J. Lipid Res. 41 (2000) 894-904
99. Gelissen I.C., Harris M., Rye K.A., Quinn C., Brown A.J., Kockx M., Cartland S., Packianathan M., Kritharides L., and Jessup W. ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 534-540
100. Szakacs G., Annereau J.P., Lababidi S., Shankavaram U., Arciello A., Bussey K.J., Reinhold W., Guo Y., Kruh G.D., Reimers M., Weinstein J.N., and Gottesman M.M. Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell 6 (2004) 129-137
101. Langmann T., Mauerer R., and Schmitz G. Human ATP-binding cassette transporter TaqMan low-density array: analysis of macrophage differentiation and foam cell formation. Clin. Chem. 52 (2006) 310-313
102. Russo G., Zegar C., and Giordano A. Advantages and limitations of microarray technology in human cancer. Oncogene 22 (2003) 6497-6507
103. Annereau J.P., Szakacs G., Tucker C.J., Arciello A., Cardarelli C., Collins J., Grissom S., Zeeberg B.R., Reinhold W., Weinstein J.N., Pommier Y., Paules R.S., and Gottesman M.M. Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance. Mol. Pharmacol. 66 (2004) 1397-1405
104. Huang Y., Anderle P., Bussey K.J., Barbacioru C., Shankavaram U., Dai Z., Reinhold W.C., Papp A., Weinstein J.N., and Sadee W. Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res. 64 (2004) 4294-4301
105. Gillet J.P., Efferth T., Steinbach D., Hamels J., de Longueville F., Bertholet V., and Remacle J. Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes. Cancer Res. 64 (2004) 8987-8993
106. Pulfer M., and Murphy R.C. Electrospray mass spectrometry of phospholipids. Mass Spectrom. Rev. 22 (2003) 332-364
107. Han X., and Gross R.W. Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom. Rev. 24 (2005) 367-412
108. Merrill Jr. A.H., Sullards M.C., Allegood J.C., Kelly S., and Wang E. Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods 36 (2005) 207-224
109. Levery S.B. Glycosphingolipid structural analysis and glycosphingolipidomics. Methods Enzymol. 405 (2005) 300-369
110. Murphy R.C., Barkley R.M., Zemski B.K., Hankin J., Harrison K., Johnson C., Krank J., McAnoy A., Uhlson C., and Zarini S. Electrospray ionization and tandem mass spectrometry of eicosanoids. Anal. Biochem. 346 (2005) 1-42
111. Brugger B., Erben G., Sandhoff R., Wieland F.T., and Lehmann W.D. Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proc. Natl. Acad. Sci. USA 94 (1997) 2339-2344
112. Liebisch G., Drobnik W., Lieser B., and Schmitz G. High-throughput quantification of lysophosphatidylcholine by electrospray ionization tandem mass spectrometry. Clin. Chem. 48 (2002) 2217-2224
113. Liebisch G., Lieser B., Rathenberg J., Drobnik W., and Schmitz G. High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm. Biochim. Biophys. Acta 1686 (2004) 108-117
114. Liebisch G., Binder M., Schifferer R., Langmann T., Schulz B., and Schmitz G. High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS). Biochim. Biophys. Acta 1761 (2006) 121-128
115. Ejsing C.S., Moehring T., Bahr U., Duchoslav E., Karas M., Simons K., and Shevchenko A. Collision-induced dissociation pathways of yeast sphingolipids and their molecular profiling in total lipid extracts: a study by quadrupole TOF and linear ion trap-orbitrap mass spectrometry. J. Mass Spectromet. 41 (2006) 372-389
116. Schwudke D., Oegema J., Burton L., Entchev E., Hannich J.T., Ejsing C.S., Kurzchalia T., and Shevchenko A. Lipid profiling by multiple precursor and neutral loss scanning driven by the data-dependent acquisition. Anal. Chem. 78 (2006) 585-595
117. Zamfir A., Vukelic Z., Bindila L., Peter-Katalinic J., Almeida R., Sterling A., and Allen M. Fully-automated chip-based nanoelectrospray tandem mass spectrometry of gangliosides from human cerebellum. J. Am. Soc. Mass Spectromet. 15 (2004) 1649-1657
118. Ekroos K., Chernushevich I.V., Simons K., and Shevchenko A. Quantitative profiling of phospholipids by multiple precursor ion scanning on a hybrid quadrupole time-of-flight mass spectrometer. Anal. Chem. 74 (2002) 941-949
119. Burkard I., Von Eckardstein A., and Rentsch K.M. Differentiated quantification of human bile acids in serum by high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 826 (2005) 147-159
120. Lembcke J., Ceglarek U., Fiedler G.M., Baumann S., Leichtle A., and Thiery J. Rapid quantification of free and esterified phytosterols in human serum using APPI-LC-MS/MS. J. Lipid Res. 46 (2005) 21-26
121. Vance J.E., and Vance D.E. Phospholipid biosynthesis in mammalian cells. Biochem. Cell Biol. 82 (2004) 113-128
122. Li Z., Agellon L.B., Allen T.M., Umeda M., Jewell L., Mason A., and Vance D.E. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab. 3 (2006) 321-331
123. Binder M., Liebisch G., Langmann T., and Schmitz G. Metabolic profiling of glycerophospholipid synthesis in fibroblasts loaded with free cholesterol and modified low density lipoproteins. J. Biol. Chem. (2006)
124. DeLong C.J., Shen Y.J., Thomas M.J., and Cui Z. Molecular distinction of phosphatidylcholine synthesis between the CDP-choline pathway and phosphatidylethanolamine methylation pathway. J. Biol. Chem. 274 (1999) 29683-29688
125. Eder K. Gas chromatographic analysis of fatty acid methyl esters. J. Chromatogr. B 671 (1995) 113-131
126. Valianpour F., Selhorst J.J., van Lint L.E., van Gennip A.H., Wanders R.J., and Kemp S. Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry. Mol. Genet. Metab. 79 (2003) 189-196
127. Neufeld E.B., Demosky Jr. S.J., Stonik J.A., Combs C., Remaley A.T., Duverger N., Santamarina-Fojo S., and Brewer Jr. H.B. The ABCA1 transporter functions on the basolateral surface of hepatocytes. Biochem. Biophys. Res. Commun. 297 (2002) 974-979
128. Ohama T., Hirano K., Zhang Z., Aoki R., Tsujii K., Nakagawa-Toyama Y., Tsukamoto K., Ikegami C., Matsuyama A., Ishigami M., Sakai N., Hiraoka H., Ueda K., Yamashita S., and Matsuzawa Y. Dominant expression of ATP-binding cassette transporter-1 on basolateral surface of Caco-2 cells stimulated by LXR/RXR ligands. Biochem. Biophys. Res. Commun. 296 (2002) 625-630
129. Chen W., Wang N., and Tall A.R. A PEST deletion mutant of ABCA1 shows impaired internalization and defective cholesterol efflux from late endosomes. J. Biol. Chem. 280 (2005) 29277-29281
130. Smith J.D., Waelde C., Horwitz A., and Zheng P. Evaluation of the role of phosphatidylserine translocase activity in ABCA1-mediated lipid efflux. J. Biol. Chem. 277 (2002) 17797-17803
131. Marks D.L., Singh R.D., Choudhury A., Wheatley C.L., and Pagano R.E. Use of fluorescent sphingolipid analogs to study lipid transport along the endocytic pathway. Methods 36 (2005) 186-195
132. Kuerschner L., Ejsing C.S., Ekroos K., Shevchenko A., Anderson K.I., and Thiele C. Polyene-lipids: a new tool to image lipids. Nat. Methods 2 (2005) 39-45
133. Kobayashi J., Okamoto H., Otabe M., Bujo H., and Saito Y. Effect of HDL, from Japanese white rabbit administered a new cholesteryl ester transfer protein inhibitor JTT-705, on cholesteryl ester accumulation induced by acetylated low density lipoprotein in J774 macrophage. Atherosclerosis 162 (2002) 131-135
134. Kenworthy A.K., Petranova N., and Edidin M. High-resolution FRET microscopy of cholera toxin B-subunit and GPI-anchored proteins in cell plasma membranes. Mol. Biol. Cell 11 (2000) 1645-1655
135. Waheed A.A., Shimada Y., Heijnen H.F., Nakamura M., Inomata M., Hayashi M., Iwashita S., Slot J.W., and Ohno-Iwashita Y. Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts). Proc. Natl. Acad. Sci. USA 98 (2001) 4926-4931
136. Schutz G.J., Kada G., Pastushenko V.P., and Schindler H. Properties of lipid microdomains in a muscle cell membrane visualized by single molecule microscopy. EMBO J. 19 (2000) 892-901
137. Kusumi A., and Suzuki K. Toward understanding the dynamics of membrane-raft-based molecular interactions. Biochim. Biophys. Acta 1746 (2005) 234-251
138. Grandl M., Bared S.M., Liebisch G., Werner T., Barlage S., and Schmitz G. E-LDL and Ox-LDL differentially regulate ceramide and cholesterol raft microdomains in human macrophages. Cytometry A 69 (2006) 189-191
139. Pfeiffer A., Bottcher A., Orso E., Kapinsky M., Nagy P., Bodnar A., Spreitzer I., Liebisch G., Drobnik W., Gempel K., Horn M., Holmer S., Hartung T., Multhoff G., Schutz G., Schindler H., Ulmer A.J., Heine H., Stelter F., Schutt C., Rothe G., Szollosi J., Damjanovich S., and Schmitz G. Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur. J. Immunol. 31 (2001) 3153-3164
140. Wolf Z., Orso E., Werner T., Boettcher A., and Schmitz G. A flow cytometric screening test for detergent-resistant surface antigens in monocytes. Cytometry A 69 (2006) 192-195